Which institution holds the most shares in Privia Health Group Inc (PRVA)

Privia Health Group Inc (NASDAQ: PRVA) is -11.85% lower on its value in year-to-date trading and has touched a low of $19.17 and a high of $30.15 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The PRVA stock was last observed hovering at around $19.81 in the last trading session, with the day’s gains setting it 0.49%.

Currently trading at $20.30, the stock is -4.19% and -7.45% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.85 million and changing 2.47% at the moment leaves the stock -16.00% off its SMA200. PRVA registered -21.38% loss for a year compared to 6-month loss of -23.74%. The firm has a 50-day simple moving average (SMA 50) of $1.31 and a 200-day simple moving average (SMA200) of $75.77.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

The stock witnessed a -11.24% gain in the last 1 month and extending the period to 3 months gives it a -11.93%, and is -1.12% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.67% over the week and 5.19% over the month.

Privia Health Group Inc (PRVA) has around 964 employees, a market worth around $2.40B and $1.58B in sales. Current P/E ratio is 66.40 and Fwd P/E is 68.76. Profit margin for the company is 2.40%. Distance from 52-week low is 5.87% and -32.67% from its 52-week high. The company has generated returns on investments over the last 12 months (6.91%).

Privia Health Group Inc quarterly earnings per share for the current quarter are estimated at $0.04 with sales reaching $730.89M over the same period.The EPS is expected to grow by 360.03% this year, but quarterly earnings will post 16.10% year-over-year. Quarterly sales are estimated to grow 15.10% in year-over-year returns.

304 institutions hold shares in Privia Health Group Inc (PRVA), with institutional investors hold 104.35% of the company’s shares. The shares outstanding are 114.69M, and float is at 101.63M with Short Float at 6.16%. Institutions hold 95.35% of the Float.

The top institutional shareholder in the company is FMR, LLC with over 14.77 million shares valued at $385.59 million. The investor’s holdings represent 12.58% of the PRVA Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 13.94 million shares valued at $363.94 million to account for 11.88% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 10.95 million shares representing 9.33% and valued at over $285.97 million, while Durable Capital Partners Lp holds 7.75% of the shares totaling 9.09 million with a market value of $237.36 million.

Privia Health Group Inc (PRVA) Insider Activity

A total of 6 insider transactions have happened at Privia Health Group Inc (PRVA) in the last six months, with sales accounting for 5 and purchases happening 1 times. The most recent transaction is an insider sale by Sullivan William M, the company’s Director. SEC filings show that Sullivan William M sold 12,000 shares of the company’s common stock on Jan 25 at a price of $23.13 per share for a total of $0.28 million. Following the sale, the insider now owns 5.45 million shares.

Privia Health Group Inc disclosed in a document filed with the SEC on Jan 24 that Sullivan William M (Director) sold a total of 9,951 shares of the company’s common stock. The trade occurred on Jan 24 and was made at $23.03 per share for $0.23 million. Following the transaction, the insider now directly holds 5.46 million shares of the PRVA stock.

Still, SEC filings show that on Dec 28, Sullivan William M (Director) disposed off 12,000 shares at an average price of $23.97 for $0.29 million. The insider now directly holds 5,474,484 shares of Privia Health Group Inc (PRVA).

Privia Health Group Inc (PRVA): Who are the competitors?

One of the company’s main competitors (and peers) include UnitedHealth Group Inc. (UNH) that is trading 5.23% up over the past 12 months.agilon health inc. (AGL) lies in the list of competitors of the Privia Health Group Inc and is -68.96% lower over the same period from PRVAHealthEquity Inc. (HQY) is 24.02% up on the 1-year trading charts.